• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SI Ge,GUO Jianyan,ZHANG Honghen,GAO Juan,ZHENG Zhonghui.Bioequivalence tests of Cetirizine Hydrochloride Teblets in healthy volunteers[J].Journal Of Pharmaceutical Research,2020,39(9):520-524[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2933times   Download 2757次 QR Code for this article
Scan with your phone!
盐酸西替利嗪片人体生物等效性试验
司鸽1,郭建艳2,张红贞2,高娟3,郑忠辉2
Font:Larger+|Default|Smaller-
(1.淄博职业学院,山东 淄博 255314;2.山东新华制药股份有限公司,山东 淄博 255035;3.山东药品食品职业学院基础教学部,山东 淄博 255011)
摘要:
目的 评价健康受试者空腹和餐后条件下单剂量服用盐酸西替利嗪片受试制剂和参比制剂是否具有生物等效性。方法 采用随机、开放、单剂量、自身交叉设计,液质联用(LC-MS/MS)法测定健康受试者空腹或餐后给药后血浆中西替利嗪的药物浓度,使用Phoenix Winnonlin 8.0软件计算药动学参数,使用SAS 9.4软件进行生物等效性评价。结果 空腹BE试验:24名健康受试者分别单次空腹服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为100.18%、96.37%、96.00%,其90%置信区间分别为95.72% ~ 14.84%、92.37% ~ 100.55%、91.77% ~ 100.42%,均落在等效区间80.00% ~ 125.00%之间;餐后BE试验:22名健康受试者分别单次餐后服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为103.98%、102.19%、101.58%,其90%置信区间分别为98.31% ~ 109.97%、98.33% ~ 106.20%、98.07% ~ 105.20%,均落在等效区间80.00% ~ 125.00%之间。结论 两种制剂对于空腹和餐后条件下的健康成年受试者具有生物等效性。
关键词:  西替利嗪  生物等效性试验  药代动力学
DOI:10.13506/j.cnki.jpr.2020.09.006
基金项目:
Bioequivalence tests of Cetirizine Hydrochloride Teblets in healthy volunteers
SI Ge1,GUO Jianyan2,ZHANG Honghen2,GAO Juan3,ZHENG Zhonghui2
(Cetirizine; Bioequivalence; Pharmacokinetic)
Abstract:
Objective To evaluate the bioequivalence of preparations and reference subjects in a single dose of cetirizine hydrochloride tablets under fasting and postprandial conditions in healthy volunteers.Methods A random, open label, single-dose, self-crossover test was designed. LC-MS/MS was applied to determine the concentration of cetirizine in plasma of healthy subjects after fasting or postprandial administration, while PHOENIX WINNONLIN 8.0 and SAS 9.4 software were used for pharmacokinetics (PK) parameters calculation and bioequivalence analysis, respectively.Results In the fast test, 24 healthy subjects took the test preparation and the reference preparation 10 mg on a single fasting. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 100.18%, 96.37%, 96.00%, respectively. The 90% confidence intervals of Cmax, AUC0-t, AUC0-∞ are 95.72% ~ 14.84%, 92.37% ~ 100.55%, 91.77% ~ 100.42%, respectively. All these data are falling within the equivalent interval of 80.00% ~ 125.00%. In the postprandial test, 22 healthy subjects took the test and reference preparations 10 mg after a single meal. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 103.98%, 102.19% 101.58%, respectively, with 90% confidence intervals of 98.31% ~ 109.97%, 98.33% ~ 106.20%, 98.07% ~ 105.20%, respectively, all of which are falling within the equivalent range of 80.00% ~ 125.00%.Conclusion The two formulations are bioequivalent to healthy adult volunteers under fasting and postprandial conditions.
Key words:  Cetirizine  Bioequivalence  Pharmacokinetic
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.